WPRIM Management System> DCMS> Chinese Critical Care Medicine> 2019> 31> 9

Volume: 31 Issue: 9

1. Formation and development of "critical care medicine with Chinese characteristics" Page:1051—1060
2. Clinical investigation on the risk factors for prognosis in patients with septic shock Page:1078—1082
3. Formation and development of "critical care medicine with Chinese characteristics" Page:1051—1060
4. Minimum quality threshold in pre-clinical sepsis studies (MQTiPSS): quality thresholds for study design and humane modeling endpoints Page:1061—1071
5. Epidemiological comparison between the new and the old diagnostic criteria for sepsis: a retrospective cohort study based on the database of Beijing Public Health Information System Page:1072—1077
6. Clinical investigation on the risk factors for prognosis in patients with septic shock Page:1078—1082
7. Clinical significance of antibacterial peptide LL-37 in early diagnosis of patients with sepsis in emergency department Page:1083—1086
8. Application effect of 1-hour bundle in the treatment of patients with sepsis Page:1087—1090
9. Effect of autophagy on expression of neutrophil programmed death ligand-1 in mice with sepsis Page:1091—1096
10. Effects of carbon monoxide release molecule-2 on sepsis-induced myocardial dysfunction in rats Page:1097—1101
11. Fecal microbiota transplantation regulates the cholinergic anti-inflammatory pathway in cerebral cortex of septic rats through intestinal microbiota Page:1102—1107
12. Effect of recombinant human thrombopoietin on endotoxin-induced thrombocytopenia in mice Page:1108—1112
13. Changes in coagulation of sepsis rats with protein-malnutrition or energy-malnutrition Page:1113—1117
14. Meta-analysis of clinical efficacy of Helmet non-invasive ventilation and oxygen therapy on patients with hypoxemic respiratory failure Page:1118—1122
15. Role and mechanism of Ly6Chigh monocyte in ventilator-induced lung injury in mice Page:1123—1127
16. Effects of circadian heart rate variation on short-term and long-term mortality in intensive care unit patients: a retrospective cohort study based on MIMIC-Ⅱ database Page:1128—1132
17. Expressions of CD4+CD45RA+ T cells and CD4+CD45RO+ T cells in peripheral blood of patients with acute coronary syndrome and their significance Page:1133—1136
18. Effects of bone marrow mesenchymal stem cells combined with normothermic mechanical perfusion on biliary epithelial cells donated after cardiac death in rats Page:1137—1142
19. Large tumor suppressor gene 2-mediated Hippo signaling pathway regulates the biological behavior of mesenchymal stem cells in vitro Page:1143—1148
20. Application of modified microbubble test in peripherally inserted central venous catheters tip positioning Page:1149—1153
21. Analysis of clinical characteristics of severe and critically ill influenza A (HIN1) Page:1154—1157
22. Design and application of a new patient transfer device Page:1158—1159
23. Progress in programmed death-1 signaling pathway in sepsis Page:1160—1162
24. Progress of antimicrobial peptides cathelicidins in infection and immunology Page:1163—1166
25. Research progress in glycogen metabolism reprogramming in sepsis associated immune cells Page:1167—1169
26. Role and mechanism of vitamin D in sepsis Page:1170—1173
27. Early prevention progress of contrast induced nephropathy Page:1174—1178
28. Application effect of 1-hour bundle in the treatment of patients with sepsis. Page:1087—1090
29. Minimum quality threshold in pre-clinical sepsis studies (MQTiPSS): quality thresholds for study design and humane modeling endpoints. Page:1061—1071
30. Epidemiological comparison between the new and the old diagnostic criteria for sepsis: a retrospective cohort study based on the database of Beijing Public Health Information System. Page:1072—1077
31. Clinical significance of antibacterial peptide LL-37 in early diagnosis of patients with sepsis in emergency department. Page:1083—1086
32. Effect of autophagy on expression of neutrophil programmed death ligand-1 in mice with sepsis. Page:1091—1096
33. Effects of carbon monoxide release molecule-2 on sepsis-induced myocardial dysfunction in rats. Page:1097—1101
34. Fecal microbiota transplantation regulates the cholinergic anti-inflammatory pathway in cerebral cortex of septic rats through intestinal microbiota. Page:1102—1107
35. Effect of recombinant human thrombopoietin on endotoxin-induced thrombocytopenia in mice. Page:1108—1112
36. Changes in coagulation of sepsis rats with protein-malnutrition or energy-malnutrition. Page:1113—1117
37. Meta-analysis of clinical efficacy of Helmet non-invasive ventilation and oxygen therapy on patients with hypoxemic respiratory failure. Page:1118—1122
38. Role and mechanism of Ly6Chigh monocyte in ventilator-induced lung injury in mice. Page:1123—1127
39. Effects of circadian heart rate variation on short-term and long-term mortality in intensive care unit patients: a retrospective cohort study based on MIMIC-II database. Page:1128—1132
40. Expressions of CD4+CD45RA+T cells and CD4+CD45RO+T cells in peripheral blood of patients with acute coronary syndrome and their significance. Page:1133—1136
41. Effects of bone marrow mesenchymal stem cells combined with normothermic mechanical perfusion on biliary epithelial cells donated after cardiac death in rats. Page:1137—1142
42. Large tumor suppressor gene 2-mediated Hippo signaling pathway regulates the biological behavior of mesenchymal stem cells in vitro. Page:1143—1148
43. Application of modified microbubble test in peripherally inserted central venous catheters tip positioning. Page:1149—1153
44. Analysis of clinical characteristics of severe and critically ill influenza A (H1N1). Page:1154—1157
45. Design and application of a new patient transfer device. Page:1158—1159
46. Progress in programmed death-1 signaling pathway in sepsis. Page:1160—1162
47. Progress of antimicrobial peptides cathelicidins in infection and immunology. Page:1163—1166
48. Research progress in glycogen metabolism reprogramming in sepsis associated immune cells. Page:1167—1169
49. Role and mechanism of vitamin D in sepsis. Page:1170—1173
50. Early prevention progress of contrast induced nephropathy. Page:1174—1178

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.